The clinical application of cancer immunotherapy based on naturally circulating dendritic cells KF Bol, G Schreibelt, K Rabold, SK Wculek, JK Schwarze, A Dzionek, ... Journal for immunotherapy of cancer 7, 1-13, 2019 | 158 | 2019 |
Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8+ T cells B Mastelic-Gavillet, B Navarro Rodrigo, L Décombaz, H Wang, ... Journal for immunotherapy of cancer 7, 1-16, 2019 | 157 | 2019 |
Siglec-9 Regulates an Effector Memory CD8+ T-cell Subset That Congregates in the Melanoma Tumor Microenvironment Q Haas, KF Boligan, C Jandus, C Schneider, C Simillion, MA Stanczak, ... Cancer immunology research 7 (5), 707-718, 2019 | 108 | 2019 |
Tumor resident memory T cells: new players in immune surveillance and therapy N Dumauthioz, S Labiano, P Romero Frontiers in immunology 9, 411458, 2018 | 95 | 2018 |
Expression of killer inhibitory receptors on cytotoxic cells from HIV‐1‐infected individuals GALIANI, AGUADO, TARAZONA, ROMERO, MOLINA, SANTAMARIA, ... Clinical & Experimental Immunology 115 (3), 472-476, 1999 | 95 | 1999 |
Very late antigen-1 marks functional tumor-resident CD8 T cells and correlates with survival of melanoma patients T Murray, SA Fuertes Marraco, P Baumgaertner, N Bordry, L Cagnon, ... Frontiers in immunology 7, 573, 2016 | 92 | 2016 |
Enforced PGC-1α expression promotes CD8 T cell fitness, memory formation and antitumor immunity N Dumauthioz, B Tschumi, M Wenes, B Marti, H Wang, F Franco, W Li, ... Cellular & molecular immunology 18 (7), 1761-1771, 2021 | 85 | 2021 |
ATP release from chemotherapy-treated dying leukemia cells elicits an immune suppressive effect by increasing regulatory T cells and tolerogenic dendritic cells M Lecciso, D Ocadlikova, S Sangaletti, S Trabanelli, E De Marchi, E Orioli, ... Frontiers in Immunology 8, 1918, 2017 | 85 | 2017 |
Future perspectives in melanoma research: Meeting report from the “Melanoma Bridge”. Napoli, December 1st–4th 2015 PA Ascierto, S Agarwala, G Botti, A Cesano, G Ciliberto, MA Davies, ... Journal of translational medicine 14, 1-25, 2016 | 80 | 2016 |
CART cells are prone to Fas-and DR5-mediated cell death BO Tschumi, N Dumauthioz, B Marti, L Zhang, P Schneider, JP Mach, ... Journal for immunotherapy of cancer 6 (1), 71, 2018 | 77 | 2018 |
18F-FDG PET metabolic-to-morphological volume ratio predicts PD-L1 tumour expression and response to PD-1 blockade in non-small-cell lung cancer M Jreige, I Letovanec, K Chaba, S Renaud, S Rusakiewicz, V Cristina, ... European journal of nuclear medicine and molecular imaging 46, 1859-1868, 2019 | 74 | 2019 |
Improving protein order-disorder classification using charge-hydropathy plots F Huang, CJ Oldfield, B Xue, WL Hsu, J Meng, X Liu, L Shen, P Romero, ... BMC bioinformatics 15, 1-13, 2014 | 71 | 2014 |
Positional scanning-synthetic peptide library-based analysis of self-and pathogen-derived peptide cross-reactivity with tumor-reactive Melan-A-specific CTL V Rubio-Godoy, V Dutoit, Y Zhao, R Simon, P Guillaume, R Houghten, ... The Journal of Immunology 169 (10), 5696-5707, 2002 | 70 | 2002 |
Analysis of the kinetics of transcription and replication of the rotavirus genome by RNA interference C Ayala-Breton, M Arias, R Espinosa, P Romero, CF Arias, S López Journal of virology 83 (17), 8819-8831, 2009 | 69 | 2009 |
Autocrine Adenosine Regulates Tumor Polyfunctional CD73+CD4+ Effector T Cells Devoid of Immune Checkpoints N Gourdin, M Bossennec, C Rodriguez, S Vigano, C Machon, C Jandus, ... Cancer research 78 (13), 3604-3618, 2018 | 68 | 2018 |
A new generation of Melan-A/MART-1 peptides that fulfill both increased immunogenicity and high resistance to biodegradation: implication for molecular anti-melanoma immunotherapy JS Blanchet, D Valmori, I Dufau, M Ayyoub, C Nguyen, P Guillaume, ... The Journal of Immunology 167 (10), 5852-5861, 2001 | 64 | 2001 |
Immuno-monitoring of CD8+ T cells in whole blood versus PBMC samples V Appay, S Reynard, V Voelter, P Romero, DE Speiser, S Leyvraz Journal of immunological methods 309 (1-2), 192-199, 2006 | 63 | 2006 |
Activation of human melanoma reactive CD8+ T cells by vaccination with an immunogenic peptide analog derived from Melan-A/melanoma antigen recognized by T cells-1 M Ayyoub, A Zippelius, MJ Pittet, D Rimoldi, D Valmori, JC Cerottini, ... Clinical cancer research 9 (2), 669-677, 2003 | 62 | 2003 |
Expression of melan‐a/MART‐1 antigen as a prognostic factor in primary cutaneous melanoma M Berset, JP Cerottini, D Guggisberg, P Romero, F Burri, D Rimoldi, ... International journal of cancer 95 (1), 73-77, 2001 | 62 | 2001 |
Survival of pathogenic microorganisms in seawater R Cornax, MA Moriñigo, P Romero, JJ Borrego Current microbiology 20, 293-298, 1990 | 61 | 1990 |